Membrane Androgen Receptor(s) and their Role in Prostate Cancer


  • Amity Institute of Biotechnology (AIB), Amity University Gurgaon, Manesar - 122413, Haryana
  • Amity Institute of Biotechnology (AIB), Amity University Gurgaon, Manesar - 122413, Haryana



Androgen, Androgen Receptor, Genomic Pathway, Non-Genomic Pathway, Prostate Cancer.


Androgens, the steroid hormones, typically mediates their action by binding to the cytosolic Androgen Receptor(s) (AR), via the classical or genomic pathway. Androgens can also act through a non-classical or non-genomic pathway interacting with receptors present on the plasma membrane of cells. Although the identity of the nuclear AR is well established, the identity of the membrane AR is still not clear. Through independent studies, three proteins have been identified that are present on plasma membranes of prostate cells and can mediate androgen signalling, viz, GPRC6A, AR8 and ZIP9. Although these proteins can mediate androgen signalling, the membrane receptor which is used most frequently and specifically for mediating androgen action in prostate cells is not confirmed. Recent research has shown that the non-genomic androgen signalling plays a key role in progression of prostate cancer (PCa). In this review, the potential of these three proteins for their ability to act as the membrane AR has been analysed. The use of membrane AR as a novel target for treatment of PCa has also been discussed.


Download data is not yet available.


Metrics Loading ...


Bagchi G, Wu J, French J, Kim J, Moniri NH, Daaka Y. Androgens transduce the Gas-mediated activation of protein kinase a in prostate cells. Cancer Res. 2008; 68(9).

Berg AH, Rice CD, Rahman MS, Dong J, Thomas P. Identification and characterization of membrane androgen receptor in the ZIP9 zinc transporter subfamily: I Discovery in female Atlantic croaker and evidence ZIP9 mediates testosterone induced apoptosis of ovarian follicle cells. Endocrinology. 2014; 155(11):4237-49. en.2014-1198 PMid:25014354 PMCid:PMC4197986

Castoria G, Migliaccio A, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. Embo J. 2000; 19(20):5406-54. PMid:11032808 PMCid:PMC314017

Cheng J, Watkins SC, Walker WH. Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells. Endocrinology. 2007; 148(5):2066-20. PMid:17272394

Conklin BR, Bourne HR. Homeostatic signals. Marriage of the flytrap and the serpent. Nature. 1994; 367(6458):22 PMid:8107768

Denmeade SR, Isaacs JT. A history of prostate cancer treatment.Nat Rev Cancer. 2002; 2(5):389-396. PMid:12044015 PMCid:PMC4124639

Foradori CD, Weiser MJ, Handa RJ. Non-genomic actions of androgens. Front Neuroendocrinol. 2008 May; 29(2):169-81. PMid:18093638 PMCid:PMC2386261

Guo C, Luttrell LM, Price DT. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines. J Urol. 2000 Mar; 163(3):1027-32. S0022-5347(05)67876-7 PMid:10688043

Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung H-J, Brodie AMH, Edwards J, Qiu Y. A novel androgen receptor splice variant is upregulated during prostate cancer progression and promotes androgen-depletion-resistant growth. Cancer Res.2009 Mar 15; 69(6):2305-13. PMid:19244107 PMCid:PMC2672822

John C, Lu LM. Abstract 4287: Intracellular trafficking of androgen receptor splice variant AR8. Mol CelBiol.2013;73(8).

Menachem K, Ido A, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta. 2007 Aug; 1773(8):1161-76. PMid:17306385 PM-Cid:PMC2758354

Kuang D, Yao Y, Maclean D, Wang M, Hampson DR, Chang BS. Ancestral reconstruction of the ligand-binding pocket of family C G protein-coupled receptors. Proc Natl Acad Sci USA. 103(38):14050-5. pnas.0604717103 PMid:16966606 PMCid:PMC1563994

Jun L, Changxue L. Decoding the androgen receptor splice variants. Transl Androl Urol. 2013 Sep; 2(3):178-86.

Franck O, Grzegorz S, Olga S, Mathieu F, Haixin C, Charles SE, Louis H. Endocrine regulation of male fertility by the skeleton. Cell. 2011 Mar 4; 144(5):796-809. PMid:21333348 PMCid:PMC3052787

Pi M, Quarles LD. GPRC6A regulates prostate cancer progression The Prostate. 2012 Mar; 72(4):399-409. https:// PMid:21681779 PMCid:PMC3183291

Pi M, Parill AL, Quarles LD. GPRC6A mediates the non-genomic effects of steroids. J Biol Chem. 2010 Dec 17; 285(51):39953-64.

Pi M, Chen L, Huang ZM, Zhu W, Ringhofer B, Luo J, Christenson L, Li B, Zhang J, Jackson DP, Faber P, Brund-en RK, Quarles D. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS ONE. 2008; 3-12.

Thomas.P, Pang Y, Dong J, Berg AH. Identification and characterization of membrane androgen receptor in the ZIP9 zinc transporter subfamily: II-Role of human ZIP9 in testosterone induced prostate and breast cancer cell apoptosis. Endocrinology. 2014 Nov; 155(11):4250-65. https:// PMid:25014355 PMCid:PMC4197988

Loomis AK, Thomas P. Effects of estrogens and xenoestrogens on androgen production by Atlantic croaker

testes in vitro: evidence for a nongenomic action mediated by an estrogen membrane receptor. Biol Reprod. 2000 Apr; 62(4):995-1004. PMid:10727269

Sarwar M. The Protein Kinase A (PKA) intracellular pathway and androgen receptor: A novel mechanism underlying the castration-resistant and metastatic prostate cancer. J Cancer Sci Ther. 2012.

Li S, Huang S, Peng S-B. Overexpression of G proteincoupled receptors in cancer cells: Involvement in tumor progression. Int J Oncol. 2005 Nov; 27(5):1329-39. https:// doi. org/10.3892/ijo.27.5.1329

Myers SA. Zinc transporters and zinc signaling: new insights into their role in type 2 diabetes. Int J Endocrinol.2015; 167503-16750. PMid:25983752 PMCid:PMC4423030

Thomas P, Braun AM. Androgens inhibit estradiol-17 beta synthesis in Atlantic croaker (Micropogonias undulates) ovaries by a non-genomic mechanism initiated at the cell surface. Biol Reprod. 2003 Nov; 69(5):1642-50. PMid:12855603

Perrot V. Neuroendocrine differentiation in the progression of prostate cancer: an update on recent developments. Open J Urol. 2012; 2:173-82. oju.2012.223032

Whitehead IP, Zohn IE, Der CJ. Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene.2001; 20(13):1547-55. sj.onc.1204188 PMid:11313901

Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 2004 Jun 23; 335:37-46. PMid:15194188

Weber RFA, Smith M, Dohle R. Androgens and male fertility.World J Urol. 2003 Nov; 21(5):341-5. PMid:14566423

Yang X, Guo Z, Sun F, Li W, Alfano A, Shimelis H, Chen M, Brodie AMH, Chen H, Xiao Z, Veenstra TD, Qiu Y. Novel membrane-associated androgen receptor splice variant potentiates proliferative and survival responses in prostate cancer cells. J Biol Chem.. 2011 Oct 14; 286(41):36152-60.




How to Cite

Pratibha Singh, J., & Bagchi Bhattacharjee, G. (2018). Membrane Androgen Receptor(s) and their Role in Prostate Cancer. Journal of Endocrinology and Reproduction, 20(2), 76–82.



Review Article